Daiichi Sankyo Korea Co., Ltd.
9
1
1
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
44%
4 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
A Study to Evaluate Effectiveness and Safety of Edoxaban in Patients 80 Years of Age or Older With Nonvalvular Atrial Fibrillation
Role: collaborator
An Observational Study Investigating the Change in Blood Cholesterol With Mevalotin® Tablet Administration in Korean Menopausal Women Aged 50 Years or More Who Require Treatment of Dyslipidemia
Role: collaborator
Efficacy and Safety of Edoxaban in Patients With Atrial Fibrillation and Mitral Stenosis
Role: collaborator
Anticoagulant Versus Dual Antiplatelet Therapy for Preventing Leaflet Thrombosis and Cerebral Embolization After Transcatheter Aortic Valve Replacement
Role: collaborator
An Observational Study Investigating the Effectiveness of Pravastatin on Renal Function in Korean Dyslipidemic Patients With Type 2 Diabetes
Role: collaborator
Effect of Pravastatin in the Subjects With Prediabetes or Early Diabetes
Role: collaborator
Optimization of Blood Pressure Management After Acute Ischemic Stroke and Its Prognostic Significance
Role: collaborator
Efficacy and Tolerability of Combination Antihypertensive Drug in Non-Responders to ARB monoTHerapy Using 24h ABPM
Role: collaborator
Effect of Renal Denervation in End Staged Renal Disease With Resistant Hypertension
Role: collaborator
All 9 trials loaded